EyePoint, Inc. (EYPT) — Institutional Holders, Q2 2026
188 institutional investment managers reported a EYPT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.3B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EYPT in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Commodore CapitalAdded · +1,775,000 sh+$25.4M
- ADAGE CAPITAL PARTNERS GP, L.L.C.Added · +1,527,792 sh+$21.8M
- TWO SIGMA INVESTMENTSAdded · +750,828 sh+$10.7M
- DIMENSIONAL FUND ADVISORSAdded · +440,625 sh+$6.3M
- AMERIPRISE FINANCIALAdded · +425,148 sh+$6.1M
Biggest sellers
- Cormorant Asset ManagementTrimmed · -1,265,000 sh-$18.1M
- MORGAN STANLEYTrimmed · -759,379 sh-$10.9M
- StemPoint CapitalTrimmed · -472,293 sh-$6.8M
- ExodusPoint Capital ManagementSold out · -458,102 sh-$6.6M
- BANK OF AMERICATrimmed · -318,395 sh-$4.6M
EYPT 13F holders ranked 1–100 of 188
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT#1 · 8,296,375 sh | 8,296,375 | $118.6M | 2.17% | 0.0% |
| 2 | BlackRock#2 · 7,463,197 sh | 7,463,197 | $106.7M | <0.01% | +4.0% |
| 3 | Cormorant Asset Management#3 · 7,000,000 sh | 7,000,000 | $100.1M | 5.13% | -15.3% |
| 4 | FEDERATED HERMES#4 · 5,681,052 sh | 5,681,052 | $81.2M | 0.12% | +0.2% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C.#5 · 4,827,792 sh | 4,827,792 | $69.0M | 0.10% | +46.3% |
| 6 | FRANKLIN RESOURCES#6 · 4,807,078 sh | 4,807,078 | $68.7M | 0.01% | -4.8% |
| 7 | Commodore Capital#7 · 4,600,000 sh | 4,600,000 | $65.8M | 3.92% | +62.8% |
| 8 | Jupiter Topco#8 · 3,770,381 sh | 3,770,381 | $53.9M | 0.02% | — |
| 9 | VANGUARD CAPITAL MANAGEMENT#9 · 3,630,252 sh | 3,630,252 | $51.9M | <0.01% | +2.0% |
| 10 | Paradigm Biocapital Advisors#10 · 2,890,397 sh | 2,890,397 | $41.3M | 0.77% | -8.0% |
| 11 | STATE STREET#11 · 2,357,545 sh | 2,357,545 | $33.7M | <0.01% | +12.4% |
| 12 | GEODE CAPITAL MANAGEMENT#12 · 2,062,390 sh | 2,062,390 | $29.5M | <0.01% | +4.0% |
| 13 | abrdn plc#13 · 2,008,802 sh | 2,008,802 | $28.7M | 0.04% | +15.6% |
| 14 | CITADEL ADVISORS#14 · 1,977,610 sh | 1,977,610 | $28.3M | <0.01% | +3.8% |
| 15 | BALYASNY ASSET MANAGEMENT L.P.#15 · 1,812,358 sh | 1,812,358 | $25.9M | 0.03% | +26.0% |
| 16 | Parkman Healthcare Partners#16 · 1,288,163 sh | 1,288,163 | $18.4M | 1.89% | -4.9% |
| 17 | EVENTIDE ASSET MANAGEMENT#17 · 1,245,583 sh | 1,245,583 | $17.8M | 0.24% | 0.0% |
| 18 | TWO SIGMA INVESTMENTS#18 · 1,181,143 sh | 1,181,143 | $16.9M | 0.01% | +174.5% |
| 19 | Essex Woodlands Management#19 · 1,084,857 sh | 1,084,857 | $15.5M | 6.10% | 0.0% |
| 20 | ORBIMED ADVISORS#20 · 1,069,147 sh | 1,069,147 | $15.3M | 0.28% | 0.0% |
| 21 | 5AM Venture Management#21 · 1,050,000 sh | 1,050,000 | $15.0M | 5.22% | 0.0% |
| 22 | Rosalind Advisors#22 · 988,230 sh | 988,230 | $14.1M | 3.73% | -4.7% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT#23 · 971,014 sh | 971,014 | $13.9M | <0.01% | +22.3% |
| 24 | AMERIPRISE FINANCIAL#24 · 848,410 sh | 848,410 | $12.1M | <0.01% | +100.4% |
| 25 | DIMENSIONAL FUND ADVISORS#25 · 841,746 sh | 841,746 | $12.0M | <0.01% | +109.8% |
| 26 | HSBC PLC#26 · 833,455 sh | 833,455 | $11.9M | <0.01% | 0.0% |
| 27 | Candriam S.C.A.#27 · 787,769 sh | 787,769 | $11.3M | 0.05% | +16.8% |
| 28 | Artia Global Partners#28 · 767,098 sh | 767,098 | $11.0M | 2.02% | 0.0% |
| 29 | Blue Owl Capital#29 · 762,594 sh | 762,594 | $10.9M | 1.64% | -16.4% |
| 30 | NORTHERN#30 · 720,917 sh | 720,917 | $10.3M | <0.01% | +6.5% |
| 31 | Patient Square Capital#31 · 720,000 sh | 720,000 | $10.3M | 1.59% | -9.4% |
| 32 | Principia Wealth Advisory#32 · 649,944 sh | 649,944 | $9.3M | 4.63% | +2.6% |
| 33 | CHARLES SCHWAB INVESTMENT MANAGEMENT#33 · 647,613 sh | 647,613 | $9.3M | <0.01% | +1.2% |
| 34 | Sio Capital Management#34 · 623,130 sh | 623,130 | $8.9M | 1.47% | -13.7% |
| 35 | VANGUARD FIDUCIARY#35 · 559,216 sh | 559,216 | $8.0M | <0.01% | +10.9% |
| 36 | Alyeska Investment Group, L.P.#36 · 509,403 sh | 509,403 | $7.3M | 0.02% | 0.0% |
| 37 | MILLENNIUM MANAGEMENT#37 · 500,093 sh | 500,093 | $7.2M | <0.01% | +5.2% |
| 38 | GOLDMAN SACHS GROUP#38 · 465,087 sh | 465,087 | $6.7M | <0.01% | -33.5% |
| 39 | Simplify Asset Management#39 · 400,044 sh | 400,044 | $5.7M | — | +22.7% |
| 40 | Ghisallo Capital Management#40 · 350,000 sh | 350,000 | $5.0M | 0.10% | New |
| 41 | StemPoint Capital#41 · 338,471 sh | 338,471 | $4.8M | 0.83% | -58.3% |
| 42 | MORGAN STANLEY#42 · 336,730 sh | 336,730 | $4.8M | <0.01% | -69.3% |
| 43 | E Fund Management , Ltd.#43 · 330,774 sh | 330,774 | $4.7M | 0.11% | +250.0% |
| 44 | Jump Financial#44 · 320,757 sh | 320,757 | $4.6M | 0.04% | +61.7% |
| 45 | Bleichroeder#45 · 316,515 sh | 316,515 | $4.5M | 0.81% | 0.0% |
| 46 | Woodline Partners#46 · 300,463 sh | 300,463 | $4.3M | 0.01% | +199.1% |
| 47 | Eversept Partners#47 · 297,735 sh | 297,735 | $4.3M | 0.22% | New |
| 48 | Rock Springs Capital Management#48 · 268,519 sh | 268,519 | $3.8M | 0.19% | +3.8% |
| 49 | CITIGROUP#49 · 266,910 sh | 266,910 | $3.8M | <0.01% | +824.1% |
| 50 | Bank of New York Mellon#50 · 250,783 sh | 250,783 | $3.6M | <0.01% | -1.8% |
| 51 | MYDA Advisors#51 · 250,000 sh | 250,000 | $3.6M | 0.53% | -24.2% |
| 52 | UBS Group AG#52 · 241,363 sh | 241,363 | $3.5M | <0.01% | +86.4% |
| 53 | BNP Paribas Asset Management Holding S.A.#53 · 234,809 sh | 234,809 | $3.4M | <0.01% | -4.3% |
| 54 | Schonfeld Strategic Advisors#54 · 229,780 sh | 229,780 | $3.3M | 0.01% | +10.9% |
| 55 | WELLINGTON MANAGEMENT GROUP LLP#55 · 228,559 sh | 228,559 | $3.3M | <0.01% | -11.7% |
| 56 | Nuveen#56 · 193,480 sh | 193,480 | $2.8M | <0.01% | -25.7% |
| 57 | Propel Bio Management#57 · 191,745 sh | 191,745 | $2.7M | 1.43% | -11.2% |
| 58 | Qube Research & Technologies Ltd#58 · 189,102 sh | 189,102 | $2.7M | <0.01% | +62.4% |
| 59 | Walleye Capital#59 · 188,221 sh | 188,221 | $2.7M | <0.01% | -37.3% |
| 60 | Susquehanna Portfolio Strategies#60 · 187,801 sh | 187,801 | $2.7M | 0.04% | +34.7% |
| 61 | SCHRODER INVESTMENT MANAGEMENT GROUP#61 · 169,334 sh | 169,334 | $2.4M | <0.01% | -22.5% |
| 62 | HighVista Strategies#62 · 155,704 sh | 155,704 | $2.2M | 0.51% | -14.9% |
| 63 | DEUTSCHE BANK AG\#63 · 152,799 sh | 152,799 | $2.2M | <0.01% | -36.1% |
| 64 | Granahan Investment Management#64 · 149,387 sh | 149,387 | $2.1M | 0.08% | -49.7% |
| 65 | Swiss National Bank#65 · 142,300 sh | 142,300 | $2.0M | <0.01% | -3.5% |
| 66 | STATE OF WISCONSIN INVESTMENT BOARD#66 · 139,770 sh | 139,770 | $2.0M | <0.01% | +10.3% |
| 67 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#67 · 135,340 sh | 135,340 | $1.9M | <0.01% | -9.7% |
| 68 | PANAGORA ASSET MANAGEMENT#68 · 132,214 sh | 132,214 | $1.9M | <0.01% | 0.0% |
| 69 | Corient Private Wealth#69 · 127,199 sh | 127,199 | $1.8M | <0.01% | -0.2% |
| 70 | PRICE T ROWE ASSOCIATES#70 · 124,989 sh | 124,989 | $1.8M | <0.01% | +17.8% |
| 71 | ESSEX INVESTMENT MANAGEMENT#71 · 121,684 sh | 121,684 | $1.7M | — | -4.3% |
| 72 | Invesco Ltd.#72 · 116,204 sh | 116,204 | $1.7M | <0.01% | -11.9% |
| 73 | Russell Investments Group, Ltd.#73 · 110,069 sh | 110,069 | $1.6M | <0.01% | +53.7% |
| 74 | Squarepoint Ops#74 · 98,002 sh | 98,002 | $1.4M | <0.01% | +22.3% |
| 75 | RHUMBLINE ADVISERS#75 · 97,437 sh | 97,437 | $1.4M | <0.01% | +0.8% |
| 76 | SG Americas Securities#76 · 88,802 sh | 88,802 | $1.3M | <0.01% | New |
| 77 | ALGERT GLOBAL#77 · 78,990 sh | 78,990 | $1.1M | 0.01% | New |
| 78 | Waverly Advisors#78 · 77,914 sh | 77,914 | $1.1M | <0.01% | 0.0% |
| 79 | Cinctive Capital Management#79 · 72,582 sh | 72,582 | $1.0M | 0.04% | +160.5% |
| 80 | WELLS FARGO & COMPANY#80 · 70,739 sh | 70,739 | $1.0M | <0.01% | +141.5% |
| 81 | WOODSTOCK#81 · 68,465 sh | 68,465 | $979.0K | — | 0.0% |
| 82 | ALLIANCEBERNSTEIN L.P.#82 · 75,336 sh | 75,336 | $971.1K | <0.01% | 0.0% |
| 83 | BANK OF AMERICA#83 · 65,048 sh | 65,048 | $930.2K | <0.01% | -83.0% |
| 84 | JANE STREET GROUP#84 · 62,939 sh | 62,939 | $900.0K | <0.01% | +70.4% |
| 85 | Zurcher Kantonalbank (Zurich Cantonalbank)#85 · 60,539 sh | 60,539 | $865.7K | <0.01% | +179.7% |
| 86 | Legal & General Group Plc#86 · 59,220 sh | 59,220 | $846.8K | <0.01% | +11.5% |
| 87 | FOX RUN MANAGEMENT, L.L.C.#87 · 58,528 sh | 58,528 | $837.0K | 0.14% | New |
| 88 | HRT FINANCIAL#88 · 57,212 sh | 57,212 | $818.0K | <0.01% | +43.0% |
| 89 | Y-Intercept (Hong Kong) Ltd#89 · 51,190 sh | 51,190 | $732.0K | — | New |
| 90 | VOYA INVESTMENT MANAGEMENT#90 · 50,089 sh | 50,089 | $716.3K | <0.01% | +4.9% |
| 91 | SILVERBACK ASSET MANAGEMENT#91 · 50,000 sh | 50,000 | $715.0K | 0.08% | 0.0% |
| 92 | JPMORGAN CHASE#92 · 50,053 sh | 50,053 | $706.2K | 0.00% | +24.8% |
| 93 | Erste Asset Management GmbH#93 · 50,000 sh | 50,000 | $705.5K | <0.01% | 0.0% |
| 94 | VANGUARD ASSET MANAGEMENT, Ltd#94 · 49,129 sh | 49,129 | $702.5K | <0.01% | 0.0% |
| 95 | Point72 Asset Management, L.P.#95 · 48,574 sh | 48,574 | $694.6K | <0.01% | New |
| 96 | SBI Okasan Asset Management Ltd.#96 · 45,700 sh | 45,700 | $644.8K | 0.02% | 0.0% |
| 97 | BARCLAYS PLC#97 · 43,948 sh | 43,948 | $628.5K | <0.01% | +68.0% |
| 98 | MetLife Investment Management#98 · 43,469 sh | 43,469 | $621.6K | <0.01% | 0.0% |
| 99 | SCOTIA CAPITAL#99 · 41,751 sh | 41,751 | $597.0K | <0.01% | 0.0% |
| 100 | Marex Group plc#100 · 41,300 sh | 41,300 | $590.6K | <0.01% | -26.7% |
Funds that sold out of EYPT in Q2 2026 (23)
Held EYPT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.